Related references
Note: Only part of the references are listed.The life and death of protein kinase C
Christine M. Gould et al.
CURRENT DRUG TARGETS (2008)
Protein kinase C isozymes and their selectivity towards ruboxistaurin
Sishi Tang et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-α-dependent pathway
Vicki Thallas-Bonke et al.
DIABETES (2008)
Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease
Katherine R. Tuttle et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Effect of ruboxistaurin on urina transforming growth factor-β in patients with diabetic nephropathy and type 2 diabetes
Richard E. Gilbert et al.
DIABETES CARE (2007)
Deletion of protein kinase C-ε signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo
Matthias Meier et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo
J. Menne et al.
KIDNEY INTERNATIONAL (2006)
PKC-α regulates cardiac contractility and propensity toward heart failure
JC Braz et al.
NATURE MEDICINE (2004)
High glucose-suppressed endothelin-1 Ca2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells
H Hua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Protein kinase C isotypes and their specific functions: Prologue
S Ohno et al.
JOURNAL OF BIOCHEMISTRY (2002)
Share Paper
